10 Best Multibagger Penny Stocks to Invest In
Small-cap and penny stocks are often overlooked by Wall Street as they tend to be extremely volatile.
Precigen Inc. (PGEN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Patient Capital Management Samantha Mclemore | 18,673,466 | $78,055,089 | -30% | 3.01% |
| 2. | Point72 Asset Management Steve Cohen | 13,724,141 | $57,366,909 | +401% | 0.06% |
| 3. | Tang Capital Management Kevin C. Tang | 5,617,500 | $23,481,150 | -55% | 1.16% |
| 4. | Diametric Capital Nick Thakore | 3,847,024 | $16,080,560 | +295% | 4.31% |
| 5. | Driehaus Capital Richard Driehaus | 3,601,674 | $15,054,997 | +77% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.40 | 2,000 | $6,800.00 | 405,959 | 2025-09-26 | Filing | |
| $3.58 | 6,000 | $21,480.00 | 65,031 | 2025-09-29 | Filing | |
| $3.42 | 2,932 | $10,027.44 | 468,626 | 2025-09-26 | Filing | |
| $3.62 | 8,284 | $29,988.08 | 465,694 | 2025-09-25 | Filing | |
| $4.60 | 15,000 | $69,000.00 | 217,841 | 2025-09-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.30 | 2,334,420 | $7,703,586.00 | 12,262,741 | 2026-03-30 | Filing | |
| $3.30 | 23,789 | $78,503.70 | 423,984 | 2026-03-30 | Filing | |
| $3.30 | 38,976 | $128,620.80 | 302,213 | 2026-03-30 | Filing | |
| $3.30 | 47,101 | $155,433.30 | 519,061 | 2026-03-30 | Filing | |
| $3.30 | 168,794 | $557,020.20 | 1,425,544 | 2026-03-30 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,000 | $3,870 | 0% | |
| 2. | 6 | $24 | 0% |
News See All
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Precigen, Inc. Full Year 2025 Financial Results and Business Updates Conference Call.
Precigen (PGEN) Surged Following the Early Approval of Papziemos
Patient Capital Management, a value investing firm, released its “Patient Opportunity Equity Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Precigen, Inc. (PGEN) Builds Commercial Stage With Global Regulatory Support
Precigen Inc. (NASDAQ:PGEN) is one of Goldman Sachs’ top penny stock picks. On January 20, Precigen Inc.
Goldman Sachs Penny Stocks: Top 12 Stock Picks
The rotation towards small and micro-cap stocks is gaining momentum.
Precigen, Inc. (NASDAQ:PGEN) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Precigen Third Quarter 2025 Financial Results and Business Updates Conference Call. At this time, all lines are in listen-only mode.
Precigen Reports Positive Long-Term Follow-Up Data for FDA-Approved RRP Therapy, PAPZIMEOS
Precigen Inc. (NASDAQ:PGEN) is one of the hot stocks to buy with huge upside potential.
12 Hot Stocks to Buy with Huge Upside Potential
On October 22, Vios Advisors’ Michael Bapis and BNY’s Alicia Levine joined CNBC's 'Closing Bell' to discuss the latest news affecting markets.
Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization
Precigen, Inc. (NASDAQ:PGEN) is a biotechnology company developing precision genetic medicines for oncology, infectious diseases, and rare conditions.
15 Best Biotech Penny Stocks to Invest in Right Now
Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.
Hedge Fund Resource Center